Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.
about
Drug Carrier for Photodynamic Cancer TherapyPhotodynamic nanomedicine in the treatment of solid tumors: perspectives and challengesA review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsNanocarriers for vascular delivery of antioxidantsEntering the era of nanoscience: time to be so small.Size Dependent Cellular Uptake of Rod-like Bionanoparticles with Different Aspect Ratios.Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.Nanotechnology for the treatment of melanoma skin cancer.PRINT: a novel platform toward shape and size specific nanoparticle theranostics.Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.Advanced molecular design of biopolymers for transmucosal and intracellular delivery of chemotherapeutic agents and biological therapeutics.pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic AgentsHybrid responsive hydrogel carriers for oral delivery of low molecular weight therapeutic agents.pH-responsive hydrogels with dispersed hydrophobic nanoparticles for the oral delivery of chemotherapeutics.Optimization of magnetosome production and growth by the magnetotactic vibrio Magnetovibrio blakemorei strain MV-1 through a statistics-based experimental design.An adsorption chromatography assay to probe bulk particle transport through hydrogels.The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter NanorodsShape matters: the diffusion rates of TMV rods and CPMV icosahedrons in a spheroid model of extracellular matrix are distinctSerum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.Alternative in vitro assays in nanomaterial toxicology.Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors.Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Targeted radiotherapy with gold nanoparticles: current status and future perspectives.Nanotechnology applications in diagnosis and treatment of metastasis.Tracing engineered nanomaterials in biological tissues using coherent anti-Stokes Raman scattering (CARS) microscopy - A critical review.Role of particle size, shape, and stiffness in design of intravascular drug delivery systems: insights from computations, experiments, and nature.pH-Responsive Wormlike Micelles with Sequential Metastasis Targeting Inhibit Lung Metastasis of Breast Cancer.Mathematical Modeling and Experimental Validation of Nanoemulsion-Based Drug Transport across Cellular Barriers.Cytotoxicity and intracellular fate of PLGA and chitosan-coated PLGA nanoparticles in Madin-Darby bovine kidney (MDBK) and human colorectal adenocarcinoma (Colo 205) cells.Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier.The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels.Pharmaceutical differences between block copolymer self-assembled and cross-linked nanoassemblies as carriers for tunable drug release.Comprehensive characterizations of nanoparticle biodistribution following systemic injection in mice.Elongated plant virus-based nanoparticles for enhanced delivery of thrombolytic therapies.The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages.Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.Meeting report VLPNPV: Session 5: Plant based technology.Engineering building blocks for self-assembling protein nanoparticles
P2860
Q26782780-7456FDBA-B5F3-47B6-A0AE-184E0C663FF9Q26827820-2D2E3C9B-F36E-4FB9-8CD7-D4720F4222D9Q27006569-22EE4EC5-92D0-42A4-82B7-78786661A23AQ27027067-C4BB3653-2D17-473E-B7A1-46C5B92AE022Q28681114-82830C49-59FF-4FB6-B737-C9C446D55CC3Q30385575-3DAB3BE1-F637-4EBB-977A-D50EFC09A5ADQ33624697-7CF13BD4-DF3B-44FC-B2F9-F5E96C13BB3AQ33694294-DAE36314-3B55-4BB1-AFE2-79519E7CD01BQ34149121-1B1A2409-DF64-4557-B70E-E7EC73681132Q34728884-24EC3AFA-56FD-4A6E-9244-2EFECF30EAE5Q35376573-EC6813F0-A77B-48C1-92AC-98985C40A991Q36327202-5B05BEAD-145F-4E67-8B0E-EEA70312C379Q36376449-47F58782-1DF6-4767-AD42-4BDB170D1075Q36746601-CD8E8B9C-597A-4AE5-99A0-35A5103EE586Q36757302-8A5BF9DF-659E-4BFC-9BED-50B59EB520D3Q36833916-D4F3FFB9-9A29-4B21-A50E-0534E5926278Q37068238-696D7D53-C73D-4814-99C7-50072022616BQ37298480-975AF133-EFC8-4EC9-A504-5EDF20572B11Q37451428-5F2D3AD5-2127-40A6-84BA-EB3D2359556EQ37902143-BE6D8E94-5E0A-46AB-8C04-FA3A2957143BQ38015528-B9F10170-453B-48B5-950C-0049C9143478Q38112171-65DBC47F-A7F8-4F2A-B759-56CD89570E3FQ38155457-3FA86C00-AC20-422D-80BC-4E6B961B8A75Q38224610-6460DB3F-3859-4707-9456-3D98E3B45BD8Q38254086-06650409-7B7F-4494-82F7-61ED218F427AQ38472660-4E85B529-734A-4146-86E1-81641E7D6D86Q38573793-EB60BA42-F5B5-45B7-B95F-58420ED4FEEAQ38808367-9E7AE8C0-F2DE-4C27-8681-587335D2B20BQ38847086-133F0925-8590-4384-90BA-65AF40EEB816Q38874656-14AE4AE7-8BDD-406E-8337-F0A8FF452A8FQ38886370-31968BA2-A2D1-4FD2-8B6E-82DDF7580C5DQ38973330-577098B0-9CCF-43B0-A52F-9A4D69DB4A74Q39192476-26449640-3DA9-439D-895B-6D817C30F992Q39262135-1CC21314-0022-4F04-A005-95F4256769B0Q39343741-7052B172-931B-486B-9AF4-B73CB02588A1Q40053619-2D6B7F84-A03C-484C-8ED3-030B0ADA9DCBQ41696512-806E41A4-3D30-45DE-A0DC-52BE7D804F7EQ42238107-280072C9-EE6E-435C-AF63-67A48D4E5649Q42346870-8CCD471F-0621-4AB0-A45C-6600057A9202Q42574574-F6034A7F-7DBD-4730-BF99-A3052C4C23F0
P2860
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Designer nanoparticles: incorp ...... into nanoscale drug carriers.
@ast
Designer nanoparticles: incorp ...... into nanoscale drug carriers.
@en
type
label
Designer nanoparticles: incorp ...... into nanoscale drug carriers.
@ast
Designer nanoparticles: incorp ...... into nanoscale drug carriers.
@en
prefLabel
Designer nanoparticles: incorp ...... into nanoscale drug carriers.
@ast
Designer nanoparticles: incorp ...... into nanoscale drug carriers.
@en
P2093
P2860
P1476
Designer nanoparticles: incorp ...... e into nanoscale drug carriers
@en
P2093
Krishnendu Roy
Mary Caldorera-Moore
Nathalie Guimard
P2860
P304
P356
10.1517/17425240903579971
P407
P50
P577
2010-04-01T00:00:00Z